Related Experiment Video
Updated: Jul 7, 2025
09:45
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
8.4K
Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer
Amartya Pal1,2, Anushka Ojha1,2, Jingfang Ju1,3
1Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
International Journal of Molecular Sciences
|December 23, 2023
Summary
MicroRNAs (miRNAs) show promise for early pancreatic cancer detection and treatment. This review explores miRNA-based therapies, including restoring tumor-suppressive miRNAs and suppressing oncogenic ones, to improve patient survival rates.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Pancreatic cancer has a low five-year survival rate, posing a significant global health challenge.
- Late diagnosis and tumor heterogeneity impede effective treatment strategies.
- Novel biomarkers are crucial for early detection and improved therapeutic interventions.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in pancreatic cancer.
- To explore the potential of miRNAs as diagnostic and therapeutic agents.
- To summarize advancements in miRNA-based therapeutic strategies for pancreatic cancer.
Main Methods:
- Literature review of studies on miRNA expression and function in pancreatic cancer.
- Analysis of research on miRNA-based therapeutic approaches.
- Examination of challenges and future directions in miRNA therapeutics.
Main Results:
- Dysregulated miRNAs are implicated in pancreatic cancer progression, metastasis, and chemoresistance.
- Differential miRNA expression profiles offer potential for novel therapeutic strategies.
- miRNA-based therapies, including restoration or suppression, show promise.
Conclusions:
- MicroRNAs are pivotal in pancreatic cancer pathogenesis and represent promising biomarkers.
- miRNA-based therapies, despite challenges, hold potential to revolutionize pancreatic cancer treatment.
- Targeted delivery and specificity are key areas for future development in miRNA therapeutics.
Related Concept Videos
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K